Treatment of hematologic neoplasms with new immunomodulatory drugs (IMiDs). [electronic resource]
Producer: 20091104Description: 1-15 p. digitalISSN:- 1534-6277
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- adverse effects
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bone Marrow -- drug effects
- Chromosome Deletion
- Chromosomes, Human, Pair 5
- Clinical Trials as Topic
- Combined Modality Therapy
- Hematologic Neoplasms -- drug therapy
- Hematopoietic Stem Cell Transplantation
- Humans
- Immunologic Factors -- adverse effects
- Lenalidomide
- Leukemia, Lymphocytic, Chronic, B-Cell -- drug therapy
- Lymphoma, Non-Hodgkin -- drug therapy
- Middle Aged
- Multiple Myeloma -- drug therapy
- Myelodysplastic Syndromes -- drug therapy
- Salvage Therapy
- Thalidomide -- adverse effects
- Venous Thromboembolism -- chemically induced
- Young Adult
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.